# KingBio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/kingbio

- Industry: Biotechnology
- Headquarters: Chongqing, China
- Website: www.kingmedpharm.com
- Latest round: Series A (Jan 1, 2023)
- Investors on record: 1

## About

Founded in 2019 and based in Chongqing, China, Chongqing Kingmed Pharma Co., Ltd., dba KingBio, is building an industry-leading organoid application platform for all scenarios, combining it with precision medicine drugs to benefit patients and serve society. In March 2026, KingBio raised an undisclosed amount of Series B funding.
KingBio specializes in providing innovative digital solutions tailored to enhance operational efficiency for businesses across various sectors. Their core product offerings include a comprehensive software platform that integrates project management, customer relationship management (CRM), and data analytics tools designed for small to medium-sized enterprises (SMEs). These products aim to streamline workflows, improve customer engagement, and facilitate data-driven decision-making. The company's clientele spans multiple geographical markets, including North America and Europe, where they serve industries such as technology, retail, and healthcare. In addition to their flagship software platform, they offer customized consulting services to assist clients in implementing and maximizing the utility of their products.
KingBio generates revenue primarily through a subscription-based model, which allows clients to access their software solutions and consulting services. Clients typically engage in annual or monthly subscription plans, providing them with tiered access to various features based on their specific needs. The company also engages in B2B transactions, forming partnerships with larger enterprises to deliver tailored solutions. Revenue is derived from these subscriptions and partnership agreements, as well as from the sale of add-on services and premium features, with a pricing structure designed to cater to the diverse requirements of their customer base.

## Funding rounds

- Series A, Jan 1, 2023 — Toposcend Capital

## Investors

- Toposcend Capital (https://capitalatlas.ai/funds/toposcend-capital) — Series A